Pembrolizumab, Paclitaxel, and Carboplatin in Patients With Advanced Stage Epithelial Ovarian Cancer (EOC).
Clinical trial NCT02834975 · TERMINATED
Trial details
- NCT number
- NCT02834975
- Sponsor
- University of Miami
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-12-22
- Primary completion
- 2022-09-01
- Enrollment
- 26
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.